Skip to main content
Uncategorised

A digital prescription for pharma companies – McKinsey & Company

By December 3, 2014No Comments

mckinsey-company-logo

The US healthcare industry is undergoing a major transformation as healthcare reform encourages consumers to play a far more active decision-making role. Yet despite this traditionally business-to-business industry moving quickly to a business-to-consumer model, companies have been slow to join the digital movement. Unlike successful B2C companies in other industries—which offer mobile solutions, provide personalized product recommendations, and empower customer-service agents with a 360-degree view of the customer—most healthcare providers and payors are lagging, as are pharmaceutical companies and medical-device manufacturers

{iframe}http://www.mckinsey.com/insights/health_systems_and_services/a_digital_prescription_for_pharma_companies?cid=other-eml-nsl-mip-mck-oth-1412{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.